(Q35783202)

10 August 2017

Optimization of PSA screening policies: a comparison of the patient and societal perspectives (English)

1 reference

10 August 2017

Jingyu Zhang

1

1 reference

10 August 2017

Brian T Denton

2

1 reference

10 August 2017

Hari Balasubramanian

3

1 reference

10 August 2017

Nilay D Shah

4

1 reference

10 August 2017

Brant A Inman

5

1 reference

10 August 2017

20 September 2011

1 reference

10 August 2017

Medical Decision Making

1 reference

10 August 2017

32

1 reference

10 August 2017

2

1 reference

10 August 2017

337-349

1 reference

Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

27 July 2018

Overdiagnosis in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Markov decision processes: a tool for sequential decision making under uncertainty

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Prostate specific antigen for early detection of prostate cancer: longitudinal study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Screening and prostate-cancer mortality in a randomized European study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Mortality results from a randomized prostate-cancer screening trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Optimal management of high-risk T1G3 bladder cancer: a decision analysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Cost analysis of screening for, diagnosing, and staging prostate cancer based on a systematic review of published studies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

A review and meta-analysis of prostate cancer utilities.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

20-year outcomes following conservative management of clinically localized prostate cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Serial prostate specific antigen screening for prostate cancer: a computer model evaluates competing strategies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Screening for prostate cancer: the roles of science, policy, and opinion in determining what is best for patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

History of the Rochester Epidemiology Project

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Screening for prostate cancer with prostate-specific antigen. An examination of the evidence

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Assessment of diagnostic tests when disease verification is subject to selection bias

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Optimal Breast Biopsy Decision-Making Based on Mammographic Features and Demographic Factors

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

ERSPC and PLCO prostate cancer screening studies: what are the differences?

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Optimizing the start time of statin therapy for patients with diabetes

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Deaths: leading causes for 2004.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3288242

Needle Biopsies on Autopsy Prostates: Sensitivity of Cancer Detection Based on True Prevalence

25 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F0272989X11416513

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

12 December 2020

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

1 reference

12 December 2020

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized Controlled Trial

1 reference

12 December 2020

Planning treatment of ischemic heart disease with partially observable Markov decision processes

1 reference

12 December 2020

Comparing the costs of radiation therapy and radical prostatectomy for the initial treatment of early-stage prostate cancer

1 reference

12 December 2020

The $64,000 question--what is a quality-adjusted life-year worth?

1 reference

12 December 2020

Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result

1 reference

12 December 2020

Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach

1 reference

12 December 2020

Identifiers

DOI

10.1177/0272989X11416513

1 reference

10 August 2017

1 reference

10 August 2017

1 reference